Stay updated on NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial

Sign up to get notified when there's something new on the NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.2 to v3.6.3, indicating a small maintenance update to the page. The change does not modify study data, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-07-04T13:22:25.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page's revision version was updated from v3.6.0 to v3.6.2, indicating a deployment update with potential minor fixes or improvements not related to the study details.
    Difference
    0.1%
    Check dated 2026-06-27T05:34:37.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page adds recruitment status indicating no participants are being sought and introduces new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study), while adjusting the Intervention/Treatment header formatting and updating the revision tag from v3.5.5 to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-13T00:19:16.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.4 to v3.5.5, signaling a minor update to the page. This change does not alter study details, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-06-05T21:43:40.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Status updated to Active, not recruiting, with enrollment reported as 107 and primary completion set for 2026-12. The principal investigator's contact information was removed from the page.
    Difference
    1%
    Check dated 2026-05-22T14:06:36.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    The page revision has been updated to v3.5.4, indicating a backend or rendering system update. No changes to the displayed study information are introduced.
    Difference
    0.1%
    Check dated 2026-05-15T11:43:18.000Z thumbnail image

Stay in the know with updates to NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial page.